New 20-Strain pneumonia vaccine moves to safety testing in china
NCT ID NCT07023081
First seen Jan 08, 2026 · Last updated May 23, 2026 · Updated 25 times
Summary
This study tests a new vaccine (20vPnC) that protects against 20 types of pneumococcal bacteria, which can cause pneumonia and other serious infections. About 200 healthy Chinese adults, children, and infants will receive the vaccine at different ages and schedules. Researchers will monitor for side effects and measure immune responses to see if the vaccine is safe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMOCOCCAL DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention
Nanning, Guangxi, 530021, China
-
Wuming District Center for Disease Control and Prevention
Chengxiang, Nanning, 530199, China
Conditions
Explore the condition pages connected to this study.